Can an apple watch help lung cancer patients during treatment?
NCT ID NCT06342284
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study will test whether lung cancer patients can use an Apple Watch, a home pulse oximeter, and a smartphone to collect health data during proton beam radiotherapy. About 40 participants will wear the devices from the start of treatment until two weeks after it ends. The goal is to see if this approach is practical and acceptable to patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could show that wearable devices are a practical way to monitor patients during cancer treatment, potentially improving care.
- What could go wrong
- This is a small, early pilot study focused on feasibility, not treatment outcomes. It may not prove any health benefits or apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
New York Proton Center
RECRUITINGNew York, New York, 10035, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Can a PET scan reveal hidden heart harm from lung cancer treatment?